0001387131-18-006984.txt : 20181221 0001387131-18-006984.hdr.sgml : 20181221 20181221200226 ACCESSION NUMBER: 0001387131-18-006984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181219 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finizio Robert G CENTRAL INDEX KEY: 0001532235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 181251031 MAIL ADDRESS: STREET 1: 951 BROKEN SOUND PARKWAY NW STREET 2: SUITE 320 CITY: BOCA RATON STATE: FL ZIP: 33487 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 561-961-1911 MAIL ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 finizio-form4_121918.xml OWNERSHIP DOCUMENT X0306 4 2018-12-19 0 0000025743 TherapeuticsMD, Inc. TXMD 0001532235 Finizio Robert G 6800 BROKEN SOUND PKWY NW, THIRD FLOOR BOCA RATON FL 33487 1 1 0 0 CEO Common Stock 2018-12-19 4 M 0 92000 0.1018 A 18458559 D Common Stock 2018-12-19 4 S 0 92000 3.698 D 18366559 D Common Stock 2018-12-20 4 M 0 92910 0.1018 A 18459469 D Common Stock 2018-12-20 4 S 0 92910 3.626 D 18366559 D Common Stock 1335136 I See footnote Common Stock 664864 I See footnote Non-Qualified Stock Option (right to buy) 0.1018 2018-12-19 4 M 0 92000 0 D 2012-01-01 2019-01-01 Common Stock 92000 92910 D Non-Qualified Stock Option (right to buy) 0.1018 2018-12-20 4 M 0 92910 0 D 2012-01-01 2019-01-01 Common Stock 92910 0 D The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.875, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 to $3.845, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. By the Reporting Person's Grantor-Retained Annuity Trust. By Robert Finizio Revocable Trust. /s/ Robert G. Finizio 2018-12-21